Photocopying cells as quickly and easily as you can photocopy a book. This is what the Aglaris Facer 1.0 will allow to be done, the first machine in the world that achieves fully automated cell production.
This project represents a definitive leap for science and research by allowing the standardized creation of cells and has been the result of 100 percent Spanish talent. The idea has emerged from three Spanish scientists -Miquel Costa, David Horna and Manuel Ángel González-, and has been able to become a reality thanks to the advice of Manuel Fuertes, general director of the Oxford University Innovation in Spain and also thanks to the financing of Kiatt, a company through which Manuel Fuertes carries out scientific transfer operations, and CRB inverbio II, which financed the company starting in December 2015. The Aglaris Cell company is now located in the Madrid Science Park.
In the field of stem cell research, it will make it possible to streamline and improve the testing processes of different therapies because cells can be generated easily, quickly and of quality. Research centers and hospitals are the potential clients most interested in their innovation.
For hospitals, the Aglaris Facer will allow the medical team to have cells quickly and safely to treat diseases that until today have no cure. A machine that does not take up much more space than a traditional photocopier and therefore replaces an entire laboratory and facilities worth no less than 1 million euros and a process full of complications.
This standardization in the production of cells will also impact the generation of drugs adapted to the needs of each patient and each ailment quickly and without the high costs that are required right now. Aglaris is currently producing five prototypes that will be made available to customers to adjust all aspects of improvement before starting mass production and putting it on the market in mid-2018. The selling price of Facer will be around 300.000 euros.
